These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 30630325)

  • 61. Severe Defects in the Macrophage Barrier to Gut Microflora in Inflammatory Bowel Disease and Colon Cancer.
    Rubio CA; Schmidt PT
    Anticancer Res; 2018 Jul; 38(7):3811-3815. PubMed ID: 29970500
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Dynamics of the human gut microbiome in inflammatory bowel disease.
    Halfvarson J; Brislawn CJ; Lamendella R; Vázquez-Baeza Y; Walters WA; Bramer LM; D'Amato M; Bonfiglio F; McDonald D; Gonzalez A; McClure EE; Dunklebarger MF; Knight R; Jansson JK
    Nat Microbiol; 2017 Feb; 2():17004. PubMed ID: 28191884
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The gut microbiome.
    Sidhu M; van der Poorten D
    Aust Fam Physician; 2017; 46(4):206-211. PubMed ID: 28376573
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Gut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease.
    Pickard JM; Zeng MY; Caruso R; Núñez G
    Immunol Rev; 2017 Sep; 279(1):70-89. PubMed ID: 28856738
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Therapeutic modulation of gut microbiota in inflammatory bowel disease: More questions to be answered.
    Qiao YQ; Cai CW; Ran ZH
    J Dig Dis; 2016 Dec; 17(12):800-810. PubMed ID: 27743467
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD.
    Sabino J; Vieira-Silva S; Machiels K; Joossens M; Falony G; Ballet V; Ferrante M; Van Assche G; Van der Merwe S; Vermeire S; Raes J
    Gut; 2016 Oct; 65(10):1681-9. PubMed ID: 27207975
    [TBL] [Abstract][Full Text] [Related]  

  • 67. How to Manipulate the Microbiota: Fecal Microbiota Transplantation.
    Fuentes S; de Vos WM
    Adv Exp Med Biol; 2016; 902():143-53. PubMed ID: 27161356
    [TBL] [Abstract][Full Text] [Related]  

  • 68. An (Anti)-Inflammatory Microbiota: Defining the Role in Inflammatory Bowel Disease?
    Burman S; Hoedt EC; Pottenger S; Mohd-Najman NS; Ó Cuív P; Morrison M
    Dig Dis; 2016; 34(1-2):64-71. PubMed ID: 26982568
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Gut microbiota differs between children with Inflammatory Bowel Disease and healthy siblings in taxonomic and functional composition: a metagenomic analysis.
    Knoll RL; Forslund K; Kultima JR; Meyer CU; Kullmer U; Sunagawa S; Bork P; Gehring S
    Am J Physiol Gastrointest Liver Physiol; 2017 Apr; 312(4):G327-G339. PubMed ID: 28039159
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Sampling Strategies for Three-Dimensional Spatial Community Structures in IBD Microbiota Research.
    Zhang S; Cao X; Huang H
    Front Cell Infect Microbiol; 2017; 7():51. PubMed ID: 28286741
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Contentious host-microbiota relationship in inflammatory bowel disease--can foes become friends again?
    Satokari R
    Scand J Gastroenterol; 2015 Jan; 50(1):34-42. PubMed ID: 25523554
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Gut microbiota: Diagnosing IBD with the gut microbiome.
    Dickson I
    Nat Rev Gastroenterol Hepatol; 2017 Apr; 14(4):195. PubMed ID: 28250469
    [No Abstract]   [Full Text] [Related]  

  • 73. Characterisation and therapeutic manipulation of the gut microbiome in inflammatory bowel disease.
    Schulberg J; De Cruz P
    Intern Med J; 2016 Mar; 46(3):266-73. PubMed ID: 26968595
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pathobiont release from dysbiotic gut microbiota biofilms in intestinal inflammatory diseases: a role for iron?
    Buret AG; Motta JP; Allain T; Ferraz J; Wallace JL
    J Biomed Sci; 2019 Jan; 26(1):1. PubMed ID: 30602371
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The gut microbiome and irritable bowel syndrome: State of art review.
    Salem AE; Singh R; Ayoub YK; Khairy AM; Mullin GE
    Arab J Gastroenterol; 2018 Sep; 19(3):136-141. PubMed ID: 29935865
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Immunopathogenesis of inflammatory bowel disease].
    Matricon J
    Med Sci (Paris); 2010 Apr; 26(4):405-10. PubMed ID: 20412746
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The potential role of fecal microbiota transplantation in the treatment of inflammatory Bowel disease.
    Khajah MA
    Scand J Gastroenterol; 2017 Nov; 52(11):1172-1184. PubMed ID: 28685630
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Diet, Gut Microbiome and Epigenetics: Emerging Links with Inflammatory Bowel Diseases and Prospects for Management and Prevention.
    Aleksandrova K; Romero-Mosquera B; Hernandez V
    Nutrients; 2017 Aug; 9(9):. PubMed ID: 28867793
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Microbiota as Therapeutic Targets.
    Xavier RJ
    Dig Dis; 2016; 34(5):558-65. PubMed ID: 27331403
    [TBL] [Abstract][Full Text] [Related]  

  • 80. IBD and the gut microbiota--from bench to personalized medicine.
    Bellaguarda E; Chang EB
    Curr Gastroenterol Rep; 2015 Apr; 17(4):15. PubMed ID: 25762474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.